Biological clock test aimed at women

Apr 25, 2008

Doctors said a blood test being offered at U.S. fertility clinics may help determine if a woman's window of opportunity for conception is closing.

The fertility test, called Plan Ahead, provides an assessment of a woman's egg supply, Repromedix Corp. said in a release. The company said Plan Ahead enables a woman to compare her estimated egg supply with the normal range expected for women of the same age.

Richard Rawlins, director of the Centers for Advanced Reproductive Care at Rush University Medical Center in Chicago, told the Chicago Tribune the test could help women who have had trouble conceiving decide if they want to go through in vitro fertilization.

The test, which costs $350, measures three hormones associated with the number of eggs in women's ovaries -- follicle stimulating hormone, anti-mullerian hormone and inhibin B.

Copyright 2008 by United Press International

Explore further: Article reviews approaches and outcomes of Africa-based HIV trials

Related Stories

Synthetic muscle ready for launch to Space Station

Apr 09, 2015

Lenore Rasmussen's dream of developing a synthetic muscle that could be used to make better prosthetic limbs and more responsive robots will literally become airborne on April 13 at 4:33 p.m. when her experiment ...

Recommended for you

Drug and device firms paid $6.5B to care providers

Jun 30, 2015

From research dollars to free lunches and junkets, drug and medical device companies paid doctors and leading hospitals nearly $6.5 billion last year, according to government data posted Tuesday.

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.